SCHEMBL32670486

SCHEMBL32670486

CCOC(=O)Cc1c(C)oc2cc(Br)ccc12

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.51
ALDH1A1 P00352 3/20 0.51
CASP1 P29466 3/20 0.51
CASP7 P55210 3/20 0.51
HSD17B10 Q99714 3/20 0.51
LMNA P02545 3/20 0.51
GLA P06280 2/20 0.51
MAPT P10636 2/20 0.51
THRB P10828 1/20 0.51
HTT P42858 1/20 0.51
ATM Q13315 1/20 0.51
L3MBTL1 Q9Y468 1/20 0.51
TBK1 Q9UHD2 1/20 0.45
TSHR P16473 3/20 0.44
GAA P10253 2/20 0.42
HPGD P15428 2/20 0.42
JAK2 O60674 1/20 0.42
PAK4 O96013 1/20 0.42
NTRK1 P04629 1/20 0.42
LCK P06239 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3595628 0.89 TSHR (0.47) KDM4EALDH1A1CASP1CASP7HSD17B10
SCHEMBL32670550 0.83 AURKA (0.43) MAPTATMSMN1; SMN2PRNP
SCHEMBL23117350 0.80 PLK1 (0.55) KDM4EALDH1A1CASP1CASP7HSD17B10
SCHEMBL25946552 0.78 TSHR (0.57) KDM4EALDH1A1HSD17B10LMNAMAPT
SCHEMBL27397704 0.78 MAPT (0.42) KDM4EALDH1A1CASP1CASP7HSD17B10
SCHEMBL14925421 0.77 ALDH1A1 (0.53) KDM4EALDH1A1CASP1CASP7HSD17B10
SCHEMBL31426301 0.76 ALOX5 (0.47) KDM4EALDH1A1CASP1CASP7HSD17B10
SCHEMBL32670275 0.76 POLB (0.56) ALDH1A1HSD17B10LMNAMAPTL3MBTL1
SCHEMBL22620634 0.76 PLK1 (0.56) KDM4EALDH1A1HSD17B10LMNAMAPT
SCHEMBL23117269 0.76 POLB (0.56) ALDH1A1HSD17B10LMNAMAPTL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260035361-A1 COMPOUNDS FOR MODULATING HUR (ELAVL1) SHANGHAI DEGRON BIOMEDICAL TECH CO LTD (CN) 2026-02-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260035361-A1 COMPOUNDS FOR MODULATING HUR (ELAVL1) ELAVL1, ELAVL3, HNRNPL KDM4E 4185/4885ALDH1A1 1434/4885CASP1 1768/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.